Southern Alberta Council on Public Affairs (SACPA)

Prompted by a drug related death epidemic that has devastated families across Alberta and indeed Canada, a former night club in Lethbridge is scheduled to become North America’s first supervised inhalation site when it opens early in 2018. To date, this facility is the only one to be granted approval by Health Canada for a site that will permit four types of drug consumption: injection, oral, intranasal and inhalation. ARCHES, the local harm reduction organization that will be operating the facility, currently support about 3,000 clients in Lethbridge and a similar number in rural areas surrounding the city. So far, Health Canada has approved six supervised consumption sites in Alberta, including four in Edmonton and one in Calgary. The latest provincial data from January to August, 2017 shows 315 individuals in Alberta died from an apparent drug overdose related to fentanyl, up more than 50 per cent from the same period last year. Per capita, Lethbridge’s drug overdose death rate exceeds that of both Calg